loaderimg
image

Cancer metastasis is responsible for 90% of cancer related deaths. In breast cancer, metastasis occurs mostly via the lymphatic system. The lymphatic nodes that are closest to a tumour are the most likely route for the cancer cells to first enter the lymphatic system and are referred to as the sentinel lymph nodes (SLN).
Diagnosing the presence of cancerous cells within the SLN is therefore critical to provide optimum treatment plans. The gold standard is currently the Sentinel Lymph Node Biopsy (SLNB). SLNB however comes with several drawbacks.
The HYPOSENS imaging system is strategically designed to offer a minimally invasive alternative to the SLNB. The device is a prognostic solution for clinicians towards, once validated more accurate and fast diagnosis and personalised treatment options.
This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 732794.

Company’s Keywords:

research, health, sentinel lymph node biopsy, cancer, medicine, breast cancer, oncology

Q How Many Employees Does This Company Have?

<0

Q Which Industry Does This Company Belong To?

Q What Is the Annual Income?

<

Q What Is the Technology of All the Company’s Website?

Q What Year Was the Company Founded?

<2016

Rate us and Write a Review

Your review is recommended to be at least 140 characters long

image

building Own or work here? Claim Now! Claim Now!

imageYour request has been submitted successfully.

image